Leipzig Heart Science Ggmbh
Clinical trials sponsored by Leipzig Heart Science Ggmbh, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Ambulance algorithm aims to speed up heart attack diagnosis Results expected Nov 2026 (estimated)
- New registry aims to crack the code of cardiac arrest survival Results expected Dec 2026 (estimated)
- New trial aims to stop deadly blood clots with quick catheter action Results expected Jun 2027 (estimated)
-
Can a temporary heart pump save more lives in cardiogenic shock?
Disease control Not yet recruitingThis trial investigates whether using a temporary heart pump (microaxial flow pump) right after opening a blocked artery improves survival in people with cardiogenic shock—a life-threatening condition where the heart can't pump enough blood. It also tests whether advanced monitor…
Sponsor: Leipzig Heart Science gGmbH • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Blood filter may tame deadly inflammation after heart attack
Disease control Not yet recruitingThis trial tests whether filtering a specific inflammatory protein (C-reactive protein, or CRP) from the blood can improve outcomes in people with cardiogenic shock—a life-threatening condition where the heart cannot pump enough blood—after a heart attack. About 50 participants w…
Sponsor: Leipzig Heart Science gGmbH • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Ambulance algorithm aims to speed up heart attack diagnosis
Knowledge-focused Not yet recruitingThis study is testing a new algorithm that helps paramedics decide if a patient with chest pain is having a heart attack. About 304 patients will get a quick blood test in the ambulance, and researchers will track their outcomes for 90 days. The goal is to fine-tune the algorithm…
Sponsor: Leipzig Heart Science gGmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC